Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults—Swedish Society of Infectious Diseases 2012

References

• Hedlund J, Strålin K, Örtqvist Å, Holmberg H. Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults. Scand J Infect Dis 2005;37:791–805.
   PubMed Web of Science ®Google Scholar
• BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001;56(Suppl 4):IV1–64.
   PubMed Web of Science ®Google Scholar
• Berntsson E, Blomberg J, Lagergard T, Trollfors B. Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol 1985;4:268–72.
   PubMedGoogle Scholar
• Holmberg H, Bodin L, Jonsson I, Krook A. Rapid aetiological diagnosis of pneumonia based on routine laboratory features. Scand J Infect Dis 1990;22:537–45.
   PubMed Web of Science ®Google Scholar
• Kalin M, Lindberg AA, Tunevall G. Etiological diagnosis of bacterial pneumonia by Gram stain and quantitative culture of expectorates. Leukocytes or alveolar macrophages as indicators of sample representativity. Scand J Infect Dis 1983;15:153–60.
   PubMed Web of Science ®Google Scholar
• Örtqvist A, Hedlund J, Grillner L, Jalonen E, Kallings I, Leinonen M, . Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J 1990;3:1105–13.
   PubMed Web of Science ®Google Scholar
• Holmberg H. Aetiology of community-acquired pneumonia in hospital treated patients. Scand J Infect Dis 1987;19:491–501.
   PubMed Web of Science ®Google Scholar
• Burman LA, Trollfors B, Andersson B, Henrichsen J, Juto P, Kallings I, . Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis 1991;163:1087–93.
   PubMed Web of Science ®Google Scholar
• Strålin K, Olcén P, Törnqvist E, Holmberg H. Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores. Scand J Infect Dis 2010;42:426–34.
   PubMed Web of Science ®Google Scholar
• Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010;50:202–9.
   PubMed Web of Science ®Google Scholar
• Fransen H, Tunevall G. Bacteria and serologic reactions against bacteria in patients hospitalized with acute respiratory illness. Scand J Infect Dis 1969;1:191–202.
   PubMedGoogle Scholar
• Lind K, Benzon MW, Jensen JS, Clyde WA Jr. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946–1995. Eur J Epidemiol 1997;13:581–6.
   PubMed Web of Science ®Google Scholar
• Lagerström F, Bader M, Foldevi M, Fredlund H, Nordin-Olsson I, Holmberg H. Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Örebro, Sweden. Clin Microbiol Infect 2003;9:645–52.
   PubMed Web of Science ®Google Scholar
• von Baum H, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis 2009;9:62.
   PubMed Web of Science ®Google Scholar
• Kallings I, Kallings LO. Epidemiological patterns in legionellosis in Sweden. Zentralbl Bakteriol Mikrobiol Hyg [A] 1983;255:71–5.
   PubMedGoogle Scholar
• Kragsbjerg P, Persson K, Holmberg H. Regional differences of Chlamydia pneumoniae as causative agent of pneumonia in Sweden. Scand J Infect Dis 1992;24:113–4.
   PubMed Web of Science ®Google Scholar
• Örtqvist A, Sterner G, Nilsson JA. Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis. Scand J Infect Dis 1985;17:377–86.
   PubMedGoogle Scholar
• Sörensen J, Forsberg P, Håkanson E, Maller R, Sederholm C, Soren L, . A new diagnostic approach to the patient with severe pneumonia. Scand J Infect Dis 1989;21:33–41.
   PubMed Web of Science ®Google Scholar
• Sörensen J, Cederholm I, Carlsson C. Pneumonia: a deadly disease despite intensive care treatment. Scand J Infect Dis 1986;18:329–35.
   PubMed Web of Science ®Google Scholar
• Eldika N, Sethi S. Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2006;12:118–24.
   PubMed Web of Science ®Google Scholar
• Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, . BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009;64(Suppl 3):iii1–55.
   PubMed Web of Science ®Google Scholar
• File TM Jr, Monte SV, Schentag JJ, Paladino JA, Klugman KP, Lavin B, . A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic. Int J Antimicrob Agents 2009;33:58–64.
   PubMed Web of Science ®Google Scholar
• Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992;15:757–61.
   PubMed Web of Science ®Google Scholar
• Boman J, Allard A, Persson K, Lundborg M, Juto P, Wadell G. Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA. J Infect Dis 1997;175:1523–6.
   PubMed Web of Science ®Google Scholar
• Ekman MR, Grayston JT, Visakorpi R, Kleemola M, Kuo CC, Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 1993;17:420–5.
   PubMed Web of Science ®Google Scholar
• Farr BM, Kaiser DL, Harrison BD, Connolly CK. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. Thorax 1989;44:1031–5.
   PubMed Web of Science ®Google Scholar
• Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, . New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990;69:307–16.
   PubMed Web of Science ®Google Scholar
• Macfarlane JT, Miller AC, Roderick Smith WH, Morris AH, Rose DH. Comparative radiographic features of community acquired Legionnaires’ disease, pneumococcal pneumonia, Mycoplasma pneumonia, and psittacosis. Thorax 1984;39:28–33.
   PubMed Web of Science ®Google Scholar
• Metlay JP, Schulz R, Li YH, Singer DE, Marrie TJ, Coley CM, . Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997;157:1453–9.
   PubMedGoogle Scholar
• Lehtomaki K, Leinonen M, Takala A, Hovi T, Herva E, Koskela M. Etiological diagnosis of pneumonia in military conscripts by combined use of bacterial culture and serological methods. Eur J Clin Microbiol Infect Dis 1988;7:348–54.
   PubMed Web of Science ®Google Scholar
• Örtqvist A, Grepe A, Julander I, Kalin M. Bacteremic pneumococcal pneumonia in Sweden: clinical course and outcome and comparison with non-bacteremic pneumococcal and mycoplasmal pneumonias. Scand J Infect Dis 1988;20:163–71.
   PubMed Web of Science ®Google Scholar
• Ponka A, Sarna S. Differential diagnosis of viral, mycoplasmal and bacteraemic pneumococcal pneumonias on admission to hospital. Eur J Respir Dis 1983;64:360–8.
   PubMedGoogle Scholar
• Bohte R, Hermans J, van den Broek PJ. Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 1996;15:201–5.
   PubMed Web of Science ®Google Scholar
• Foy HM, Kenny GE, McMahan R, Mansy AM, Grayston JT. Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA 1970;214:1666–72.
   PubMed Web of Science ®Google Scholar
• Woodhead MA, Macfarlane JT. Comparative clinical and laboratory features of Legionella with pneumococcal and Mycoplasma pneumonias. Br J Dis Chest 1987;81:133–9.
   PubMedGoogle Scholar
• Sopena N, Pedro-Botet ML, Sabria M, Garcia-Pares D, Reynaga E, Garcia-Nunez M. Comparative study of community-acquired pneumonia caused by Streptococcus pneumoniae, Legionella pneumophila or Chlamydia pneumoniae. Scand J Infect Dis 2004;36:330–4.
   PubMed Web of Science ®Google Scholar
• Mulazimoglu L, Yu VL. Can legionnaires disease be diagnosed by clinical criteria? A critical review. Chest 2001;120:1049–53.
   Google Scholar
• Cunha BA. Clinical features of legionnaires’ disease. Semin Respir Infect 1998;13:116–27.
   PubMedGoogle Scholar
• Fernandez JA, Lopez P, Orozco D, Merino J. Clinical study of an outbreak of Legionnaire's disease in Alcoy, southeastern Spain. Eur J Clin Microbiol Infect Dis 2002;21:729–35.
   PubMed Web of Science ®Google Scholar
• Sopena N, Sabria-Leal M, Pedro-Botet ML, Padilla E, Dominguez J, Morera J, . Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest 1998;113:1195–200.
   PubMed Web of Science ®Google Scholar
• Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, . A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243–50.
   PubMed Web of Science ®Google Scholar
• Fine MJ, Singer DE, Hanusa BH, Lave JR, Kapoor WN. Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med 1993;94:153–9.
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–29.
   PubMed Web of Science ®Google Scholar
• Ewig S, Ruiz M, Mensa J, Marcos MA, Martinez JA, Arancibia F, . Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med 1998;158:1102–8.
   PubMed Web of Science ®Google Scholar
• Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, . Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001;56:296–301.
   PubMed Web of Science ®Google Scholar
• Yealy DM, Auble TE, Stone RA, Lave JR, Meehan TP, Graff LG, . Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med 2005;143:881–94.
   PubMed Web of Science ®Google Scholar
• Orrick JJ, Segal R, Johns TE, Russell W, Wang F, Yin DD. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to Infectious Diseases Society of America guidelines. Pharmacoeconomics 2004;22:751–7.
   PubMed Web of Science ®Google Scholar
• Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, . Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377–82.
   PubMed Web of Science ®Google Scholar
• Barlow G, Nathwani D, Davey P. The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax 2007;62:253–9.
   PubMed Web of Science ®Google Scholar
• Bauer TT, Ewig S, Marre R, Suttorp N, Welte T. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006;260:93–101.
   PubMed Web of Science ®Google Scholar
• Capelastegui A, Espana PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, . Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006;27:151–7.
   PubMed Web of Science ®Google Scholar
• Myint PK, Kamath AV, Vowler SL, Maisey DN, Harrison BD. Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 2006;35:286–91.
   PubMed Web of Science ®Google Scholar
• Bont J, Hak E, Hoes AW, Macfarlane JT, Verheij TJ. Predicting death in elderly patients with community-acquired pneumonia: a prospective validation study reevaluating the CRB-65 severity assessment tool. Arch Intern Med 2008;168:1465–8.
   PubMedGoogle Scholar
• Chalmers JD, Singanayagam A, Akram AR, Mandal P, Short PM, Choudhury G, . Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax 2010;65:878–83.
   PubMed Web of Science ®Google Scholar
• Kruger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, . Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008;31:349–55.
   PubMed Web of Science ®Google Scholar
• Loke YK, Kwok CS, Niruban A, Myint PK. Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Thorax 2010;65:884–90.
   PubMed Web of Science ®Google Scholar
• Man SY, Lee N, Ip M, Antonio GE, Chau SS, Mak P, . Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 2007;62:348–53.
   PubMed Web of Science ®Google Scholar
• Schaaf B, Kruse J, Rupp J, Reinert RR, Droemann D, Zabel P, . Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia. Eur Respir J 2007;30:517–24.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Koller M, Christ-Crain M, Steyerberg E, Stolz D, Muller C, . Predicting mortality with pneumonia severity scores: importance of model recalibration to local settings. Epidemiol Infect 2008;136:1628–37.
   PubMed Web of Science ®Google Scholar
• Strålin K. Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia. Int J Antimicrob Agents 2008;31:3–11.
   PubMed Web of Science ®Google Scholar
• Meehan TP, Fine MJ, Krumholz HM, Scinto JD, Galusha DH, Mockalis JT, . Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997;278:2080–4.
   PubMed Web of Science ®Google Scholar
• Bartlett JG, Finegold SM. Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates. Am Rev Respir Dis 1978;117:1019–27.
   PubMed Web of Science ®Google Scholar
• Drew WL. Value of sputum culture in diagnosis of pneumococcal pneumonia. J Clin Microbiol 1977;6:62–5.
   PubMed Web of Science ®Google Scholar
• Cordero E, Pachon J, Rivero A, Giron-Gonzalez JA, Gomez-Mateos J, Merino MD, . Usefulness of sputum culture for diagnosis of bacterial pneumonia in HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002; 21:362–7.
   PubMed Web of Science ®Google Scholar
• Musher DM, Montoya R, Wanahita A. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2004;39:165–9.
   PubMed Web of Science ®Google Scholar
• Fishman JA, Roth RS, Zanzot E, Enos EJ, Ferraro MJ. Use of induced sputum specimens for microbiologic diagnosis of infections due to organisms other than Pneumocystis carinii. J Clin Microbiol 1994;32:131–4.
   PubMed Web of Science ®Google Scholar
• Chuard C, Fracheboud D, Regamey C. Effect of sputum induction by hypertonic saline on specimen quality. Diagn Microbiol Infect Dis 2001;39:211–4.
   PubMed Web of Science ®Google Scholar
• Murray PR, Washington JA. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 1975;50:339–44.
   PubMed Web of Science ®Google Scholar
• Hedlund J, Örtqvist A, Kalin M. Nasopharyngeal culture in the pneumonia diagnosis. Infection 1990;18:283–5.
   PubMed Web of Science ®Google Scholar
• Kalin M. Bacteremic pneumococcal pneumonia: value of culture of nasopharyngeal specimens and examination of washed sputum specimens. Eur J Clin Microbiol 1982;1:394–6.
   PubMedGoogle Scholar
• Strålin K, Törnqvist E, Kaltoft MS, Olcén P, Holmberg H. Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples. J Clin Microbiol 2006;44:643–5.
   PubMed Web of Science ®Google Scholar
• Murdoch DR, Laing RT, Mills GD, Karalus NC, Town GI, Mirrett S, . Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community- acquired pneumonia. J Clin Microbiol 2001;39:3495–8.
   PubMed Web of Science ®Google Scholar
• Gutierrez F, Masia M, Rodriguez JC, Ayelo A, Soldan B, Cebrian L, . Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin Infect Dis 2003;36:286–92.
   PubMed Web of Science ®Google Scholar
• Smith MD, Derrington P, Evans R, Creek M, Morris R, Dance DA, . Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol 2003;41:2810–3.
   PubMed Web of Science ®Google Scholar
• Roson B, Fernandez-Sabe N, Carratala J, Verdaguer R, Dorca J, Manresa F, . Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin Infect Dis 2004;38:222–6.
   PubMed Web of Science ®Google Scholar
• Strålin K, Kaltoft MS, Konradsen HB, Olcén P, Holmberg H. Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia. J Clin Microbiol 2004;42:3620–5.
   PubMed Web of Science ®Google Scholar
• Andreo F, Dominguez J, Ruiz J, Blanco S, Arellano E, Prat C, . Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults. Respir Med 2006;100:884–91.
   PubMed Web of Science ®Google Scholar
• Murdoch DR, Laing RT, Cook JM. The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD. Clin Infect Dis 2003;37:153–4.
   PubMed Web of Science ®Google Scholar
• Marcos MA, Jimenez de Anta MT, de la Bellacasa JP, Gonzalez J, Martinez E, Garcia E, . Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J 2003;21:209–14.
   PubMed Web of Science ®Google Scholar
• Johansson N, Kalin M, Giske CG, Hedlund J. Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagn Microbiol Infect Dis 2008;60:255–61.
   PubMed Web of Science ®Google Scholar
• Abdeldaim GM, Strålin K, Korsgaard J, Blomberg J, Welinder-Olsson C, Herrmann B. Multiplex quantitative PCR for detection of lower respiratory tract infection and meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis. BMC Microbiol 2010;10:310.
   PubMed Web of Science ®Google Scholar
• Abdeldaim G, Herrmann B, Mölling P, Holmberg H, Blomberg J, Olcén P, . Usefulness of real-time PCR for lytA, ply, and Spn9802 on plasma samples for the diagnosis of pneumococcal pneumonia. Clin Microbiol Infect 2010;16:1135–41.
   PubMed Web of Science ®Google Scholar
• Avni T, Mansur N, Leibovici L, Paul M. PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis. J Clin Microbiol 2010;48:489–96.
   PubMed Web of Science ®Google Scholar
• Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004;17:697–728.
   PubMed Web of Science ®Google Scholar
• Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 2003;9:263–73.
   PubMed Web of Science ®Google Scholar
• Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, . Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001;33:492–503.
   PubMed Web of Science ®Google Scholar
• Kashuba AD, Ballow CH. Legionella urinary antigen testing: potential impact on diagnosis and antibiotic therapy. Diagn Microbiol Infect Dis 1996;24:129–39.
   PubMed Web of Science ®Google Scholar
• Blazquez RM, Espinosa FJ, Martinez-Toldos CM, Alemany L, Garcia-Orenes MC, Segovia M. Sensitivity of urinary antigen test in relation to clinical severity in a large outbreak of Legionella pneumonia in Spain. Eur J Clin Microbiol Infect Dis 2005;24:488–91.
   PubMed Web of Science ®Google Scholar
• Bernander S, Hanson HS, Johansson B, Von Stedingk LV. A nested polymerase chain reaction for detection of Legionella pneumophila in clinical specimens. Clin Microbiol Infect 1997;3:95–101.
   PubMedGoogle Scholar
• Murdoch DR. Nucleic acid amplification tests for the diagnosis of pneumonia. Clin Infect Dis 2003;36:1162–70.
   PubMed Web of Science ®Google Scholar
• Petric M, Comanor L, Petti CA. Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J Infect Dis 2006;194(Suppl 2):S98–110.
   Google Scholar
• Hurt AC, Alexander R, Hibbert J, Deed N, Barr IG. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol 2007;39:132–5.
   PubMed Web of Science ®Google Scholar
• Nilsson AC, Alemo B, Bjorkman P, Dillner L, Melhus A, Nilsson B, . Around-the-clock, rapid diagnosis of influenza by means of membrane chromatography antigen testing confirmed by polymerase chain reaction. Infect Control Hosp Epidemiol 2008;29:177–9.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Baselski V. The role of bronchoalveolar lavage in diagnosing nonopportunistic bacterial pneumonia. Chest 1991;100:179–90.
   PubMed Web of Science ®Google Scholar
• Pereira Gomes JC, Pedreira WL Jr, Araujo EM, Soriano FG, Negri EM, Antonangelo L, . Impact of BAL in the management of pneumonia with treatment failure: positivity of BAL culture under antibiotic therapy. Chest 2000;118:1739–46.
   PubMed Web of Science ®Google Scholar
• Musher DM. How contagious are common respiratory tract infections? N Engl J Med 2003;348:1256–66.
   PubMed Web of Science ®Google Scholar
• Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579–87.
   PubMed Web of Science ®Google Scholar
• Olsson-Liljequist B, Henriques Normark B, Struwe J, Söderblom T. Streptococcus pneumoniae: Annual Resistance Surveillance and Quality Control (RSQC) programme. In: Cars O, Olsson-Liljequist B, editors. SWEDRES 2006: a report on Swedish antibiotic utilisation and resistance in human medicine. Solna: Smittskyddsinstitutet; 2006 pp 22–3.
   Google Scholar
• SWEDRES: a report on Swedish antibiotic utilisation and resistance in human medicine. Solna: Smittskyddsinstitutet; 2011. Available at: http://www.smittskyddsinstitutet.se/upload/Publikationer/swedres-2010.pdf.
   Google Scholar
• Okazaki N, Ohya H, Sasaki T. Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976–2006: emergence of macrolide-resistant strains. Jpn J Infect Dis 2007;60:325–6.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, . Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob Agents Chemother 2009;53:2160–2.
   PubMed Web of Science ®Google Scholar
• Pereyre S, Charron A, Renaudin H, Bebear C, Bebear CM. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol 2007;45:3534–9.
   PubMed Web of Science ®Google Scholar
• Dumke R, Catrein I, Pirkil E, Herrmann R, Jacobs E. Subtyping of Mycoplasma pneumoniae isolates based on extended genome sequencing and on expression profiles. Int J Med Microbiol 2003;292:513–25.
   PubMed Web of Science ®Google Scholar
• Barkai G, Greenberg D, Givon-Lavi N, Dreifuss E, Vardy D, Dagan R. Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis 2005;11:829–37.
   PubMed Web of Science ®Google Scholar
• Baquero F. Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. J Antimicrob Chemother 1996;38(Suppl A):117–32.
   PubMedGoogle Scholar
• Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, Perea EJ, Perez-Cano R, . Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 2006;42:37–45.
   PubMed Web of Science ®Google Scholar
• Ena J, Arjona F, Martinez-Peinado C, Lopez-Perezagua Mdel M, Amador C. Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology 2006;68:1169–74.
   PubMed Web of Science ®Google Scholar
• Urbanek K, Kolar M, Loveckova Y, Strojil J, Santava L. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. J Clin Pharm Ther 2007;32:403–8.
   PubMed Web of Science ®Google Scholar
• Paterson DL. ‘Collateral damage’ from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004;38(Suppl 4):S341–5.
   Web of Science ®Google Scholar
• MacKenzie FM, Bruce J, Struelens MJ, Goossens H, Mollison J, Gould IM. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals. Clin Microbiol Infect 2007;13:269–76.
   PubMed Web of Science ®Google Scholar
• Lee SS, Kim HS, Kang HJ, Kim JK, Chung DR. Rapid spread of methicillin-resistant Staphylococcus aureus in a new hospital in the broad-spectrum antibiotic era. J Infect 2007;55:358–62.
   PubMed Web of Science ®Google Scholar
• LeBlanc L, Pepin J, Toulouse K, Ouellette MF, Coulombe MA, Corriveau MP, . Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 2006;12:1398–405.
   PubMed Web of Science ®Google Scholar
• Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, . Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996;275:134–41.
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, . Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27–72.
   PubMed Web of Science ®Google Scholar
• Hedlund J, Örtqvist A, Ahlqvist T, Augustinsson A, Beckman H, Blanck C, . Management of patients with community-acquired pneumonia treated in hospital in Sweden. Scand J Infect Dis 2002;34:887–92.
   PubMed Web of Science ®Google Scholar
• Mills GD, Oehley MR, Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 2005;330:456.
   PubMed Web of Science ®Google Scholar
• Shefet D, Robenshtok E, Paul M, Leibovici L. Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med 2005;165:1992–2000.
   PubMed Web of Science ®Google Scholar
• Chan R, Hemeryck L, O’Regan M, Clancy L, Feely J. Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial. BMJ 1995;310:1360–2.
   PubMed Web of Science ®Google Scholar
• MacGregor RR, Graziani AL. Oral administration of antibiotics: a rational alternative to the parenteral route. Clin Infect Dis 1997;24:457–67.
   PubMed Web of Science ®Google Scholar
• Castro-Guardiola A, Viejo-Rodriguez AL, Soler-Simon S, Armengou-Arxe A, Bisbe-Company V, Penarroja-Matutano G, . Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial. Am J Med 2001;111:367–74.
   PubMed Web of Science ®Google Scholar
• Nordbring F. Current practice in penicillin dosing. J Antimicrob Chemother 1981;8(Suppl C):1–6.
   PubMed Web of Science ®Google Scholar
• Örtqvist A. Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective. J Antimicrob Chemother 1995;35:205–12.
   PubMed Web of Science ®Google Scholar
• Fredlund H, Bodin L, Back E, Holmberg H, Krook A, Rydman H. Antibiotic therapy in pneumonia: a comparative study of parenteral and oral administration of penicillin. Scand J Infect Dis 1987;19:459–66.
   PubMed Web of Science ®Google Scholar
• Lidman C, Burman LG, Lagergren A, Örtqvist Å. Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia. Scand J Infect Dis 2002;34:873–9.
   PubMed Web of Science ®Google Scholar
• Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, . A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002;8:278–82.
   PubMed Web of Science ®Google Scholar
• Backhaus E, Berg S, Trollfors B, Andersson R, Persson E, Claesson BE, . Antimicrobial susceptibility of invasive pneumococcal isolates from a region in south-west Sweden 1998–2001. Scand J Infect Dis 2007;39:19–27.
   PubMed Web of Science ®Google Scholar
• Woodhead M, Blasi F, Ewig S, Huchon G, Leven M, Örtqvist Å, . Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005;26:1138–80.
   PubMed Web of Science ®Google Scholar
• Pallares R. Treatment of pneumococcal pneumonia. Semin Respir Infect 1999;14:276–84.
   PubMedGoogle Scholar
• Garau J. Role of beta-lactam agents in the treatment of community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2005;24:83–99.
   PubMed Web of Science ®Google Scholar
• Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589–96.
   PubMed Web of Science ®Google Scholar
• Waterer GW. Are macrolides now obligatory in severe community-acquired pneumonia? Intensive Care Med 2010;36:562–4.
   PubMed Web of Science ®Google Scholar
• Martin-Loeches I, Lisboa T, Rodriguez A, Putensen C, Annane D, Garnacho-Montero J, . Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 2010;36:612–20.
   PubMed Web of Science ®Google Scholar
• Tessmer A, Welte T, Martus P, Schnoor M, Marre R, Suttorp N. Impact of intravenous beta-lactam/macrolide versus beta-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia. J Antimicrob Chemother 2009;63:1025–33.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Mendia A, Sirvent JM, Barcenilla F, de la Torre-Prados MV, Sole-Violan J, . Combination antibiotic therapy improves survival in patients with community- acquired pneumonia and shock. Crit Care Med 2007;35:1493–8.
   PubMed Web of Science ®Google Scholar
• Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001;161:1837–42.
   PubMedGoogle Scholar
• Dwyer R, Ortqvist A, Aufwerber E, Henriques Normark B, Marrie TJ, Mufson MA, . Addition of a macrolide to a ss-lactam in bacteremic pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 2006;25:518–21.
   PubMed Web of Science ®Google Scholar
• Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Wittebole X, . Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care 2010;14:R126.
   PubMed Web of Science ®Google Scholar
• Oosterheert JJ, Bonten MJ, Schneider MM, Buskens E, Lammers JW, Hustinx WM, . Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ 2006;333:1193.
   PubMed Web of Science ®Google Scholar
• Nathwani D. Sequential switch therapy for lower respiratory tract infections: a European perspective. Chest 1998;113(3 Suppl):211S–218S.
   Web of Science ®Google Scholar
• HalmEA, FineMJ, KapoorWN, SingerDE, MarrieTJ, SiuAL. Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia. Arch Intern Med 2002;162:1278–84.
   PubMedGoogle Scholar
• Rhew DC, Tu GS, Ofman J, Henning JM, Richards MS, Weingarten SR. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis. Arch Intern Med 2001;161:722–7.
   PubMedGoogle Scholar
• Cunha BA. Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia. Am J Med 2001;111:412–3.
   PubMed Web of Science ®Google Scholar
• Edelstein PH. Antimicrobial chemotherapy for Legionnaires disease: time for a change. Ann Intern Med 1998;129:328–30.
   PubMed Web of Science ®Google Scholar
• Mykietiuk A, Carratala J, Fernandez-Sabe N, Dorca J, Verdaguer R, Manresa F, . Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis 2005;40:794–9.
   PubMed Web of Science ®Google Scholar
• Blazquez Garrido RM, Espinosa Parra FJ, Alemany Frances L, Ramos Guevara RM, Sanchez-Nieto JM, Segovia Hernandez M, . Antimicrobial chemotherapy for legionnaires disease: levofloxacin versus macrolides. Clin Infect Dis 2005;40:800–6.
   PubMed Web of Science ®Google Scholar
• Plouffe JF, Breiman RF, Fields BS, Herbert M, Inverso J, Knirsch C, . Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. Clin Infect Dis 2003;37:1475–80.
   PubMed Web of Science ®Google Scholar
• Siegel RE, Alicea M, Lee A, Blaiklock R. Comparison of 7 versus 10 days of antibiotic therapy for hospitalized patients with uncomplicated community-acquired pneumonia: a prospective, randomized, double-blind study. Am J Ther 1999;6:217–22.
   PubMedGoogle Scholar
• el Moussaoui R, de Borgie CA, van den Broek P, Hustinx WN, Bresser P, van den Berk GE, . Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 2006;332:1355.
   PubMed Web of Science ®Google Scholar
• Dunbar LM, Wunderink RG, Habib MP, Smith LG, Tennenberg AM, Khashab MM, . High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 2003;37:752–60.
   PubMed Web of Science ®Google Scholar
• Dunbar LM, Khashab MM, Kahn JB, Zadeikis N, Xiang JX, Tennenberg AM. Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens. Curr Med Res Opin 2004;20:555–63.
   PubMed Web of Science ®Google Scholar
• Behandling och profylax av influensa med antivirala medel. Läkemedelsverket 2007;5:11–30.
   Google Scholar
• Rekommendationer för profylax och behandling av influensa under postpandemisk fas. Socialstyrelsen; 2010.
   Google Scholar
• Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003;163:1667–72.
   PubMed Web of Science ®Google Scholar
• McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, . Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007;45:1568–75.
   PubMed Web of Science ®Google Scholar
• Ruf BR, Szucs T. Reducing the burden of influenza-associated complications with antiviral therapy. Infection 2009;37:186–96.
   PubMed Web of Science ®Google Scholar
• Brink M, Claesson J, Cronqvist J, Golster M, Kawati R, Martling CR, . Synpunkter på intensivvård av patienter med nya influensan A(H1N1). SFAIs Fokusgrupp för Influensapandemi. Svensk Förening för Anestesi och Intensivvård; 2009.
   Google Scholar
• Kiatboonsri S, Kiatboonsri C, Theerawit P. Fatal respiratory events caused by zanamivir nebulization. Clin Infect Dis 2010;50:620.
   PubMed Web of Science ®Google Scholar
• Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)—United States, May–August 2009. MMWR Morb Mortal Wkly Rep 2009;58:1071–4.
   PubMedGoogle Scholar
• Bjorkqvist M, Wiberg B, Bodin L, Barany M, Holmberg H. Bottle-blowing in hospital-treated patients with community-acquired pneumonia. Scand J Infect Dis 1997;29:77–82.
   PubMed Web of Science ®Google Scholar
• Mundy LM, Leet TL, Darst K, Schnitzler MA, Dunagan WC. Early mobilization of patients hospitalized with community-acquired pneumonia. Chest 2003;124:883–9.
   PubMed Web of Science ®Google Scholar
• Crimi C, Noto A, Princi P, Esquinas A, Nava S. A European survey of noninvasive ventilation practices. Eur Respir J 2010;36:362–9.
   PubMed Web of Science ®Google Scholar
• Wood KA, Lewis L, Von Harz B, Kollef MH. The use of noninvasive positive pressure ventilation in the emergency department: results of a randomized clinical trial. Chest 1998;113:1339–46.
   PubMed Web of Science ®Google Scholar
• Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med 2003;168:1438–44.
   PubMed Web of Science ®Google Scholar
• Confalonieri M, Potena A, Carbone G, Porta RD, Tolley EA, Umberto Meduri G. Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med 1999;160(5 Pt 1):1585–91.
   PubMed Web of Science ®Google Scholar
• Delclaux C, L’Her E, Alberti C, Mancebo J, Abroug F, Conti G, . Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: a randomized controlled trial. JAMA 2000;284:2352–60.
   PubMed Web of Science ®Google Scholar
• Cosentini R, Brambilla AM, Aliberti S, Bignamini A, Nava S, Maffei A, . Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial. Chest 2010;138:114–20.
   PubMed Web of Science ®Google Scholar
• Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000;355:1931–5.
   PubMed Web of Science ®Google Scholar
• Nava S, Hill N. Non-invasive ventilation in acute respiratory failure. Lancet 2009;374:250–9.
   PubMed Web of Science ®Google Scholar
• Briel M, Bucher HC, Boscacci R, Furrer H. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection. Cochrane Database Syst Rev 2006;(3):CD006150.
   Google Scholar
• Walters JA, Gibson PG, Wood-Baker R, Hannay M, Walters EH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2009;(1):CD001288.
   Google Scholar
• Meijvis SC, Hardeman H, Remmelts HH, Heijligenberg R, Rijkers GT, van Velzen-Blad H, . Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet 2011;377:2023–30.
   PubMed Web of Science ®Google Scholar
• Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, . Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005;171:242–8.
   PubMed Web of Science ®Google Scholar
• Mikami K, Suzuki M, Kitagawa H, Kawakami M, Hirota N, Yamaguchi H, . Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization. Lung 2007;185:249–55.
   PubMed Web of Science ®Google Scholar
• Monton C, Ewig S, Torres A, El-Ebiary M, Filella X, Rano A, . Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. Eur Respir J 1999;14:218–20.
   PubMed Web of Science ®Google Scholar
• Salluh JI, Povoa P, Soares M, Castro-Faria-Neto HC, Bozza FA, Bozza PT. The role of corticosteroids in severe community-acquired pneumonia: a systematic review. Crit Care 2008;12:R76.
   PubMed Web of Science ®Google Scholar
• Gorman SK, Slavik RS, Marin J. Corticosteroid treatment of severe community-acquired pneumonia. Ann Pharmacother 2007;41:1233–7.
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, . Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006;174:84–93.
   PubMed Web of Science ®Google Scholar
• Bruns AH, Oosterheert JJ, Hak E, Hoepelman AI. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J 2008;32:726–32.
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008;121:219–25.
   PubMed Web of Science ®Google Scholar
• Brown JS. Biomarkers and community-acquired pneumonia. Thorax 2009;64:556–8.
   PubMed Web of Science ®Google Scholar
• Roson B, Carratala J, Fernandez-Sabe N, Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with community- acquired pneumonia. Arch Intern Med 2004;164:502–8.
   PubMedGoogle Scholar
• Rome L, Murali G, Lippmann M. Nonresolving pneumonia and mimics of pneumonia. Med Clin North Am 2001;85:1511–30, xi.
   PubMed Web of Science ®Google Scholar
• Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, . Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730–54.
   PubMed Web of Science ®Google Scholar
• Heffner JE, McDonald J, Barbieri C, Klein J. Management of parapneumonic effusions. An analysis of physician practice patterns. Arch Surg 1995;130:433–8.
   PubMedGoogle Scholar
• Davies HE, Davies RJ, Davies CW. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65(Suppl 2):ii41–53.
   PubMed Web of Science ®Google Scholar
• Diacon AH, Brutsche MH, Soler M. Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound. Chest 2003;123:436–41.
   PubMed Web of Science ®Google Scholar
• Pothula V, Krellenstein DJ. Early aggressive surgical management of parapneumonic empyemas. Chest 1994;105:832–6.
   PubMed Web of Science ®Google Scholar
• Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006;174:817–23.
   PubMed Web of Science ®Google Scholar
• Almirall J, Gonzalez CA, Balanzo X, Bolibar I. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest 1999;116:375–9.
   PubMed Web of Science ®Google Scholar
• Holmberg H, Kragsbjerg P. Association of pneumonia and lung cancer: the value of convalescent chest radiography and follow-up. Scand J Infect Dis 1993;25:93–100.
   PubMedGoogle Scholar
• Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987;1:671–4.
   PubMed Web of Science ®Google Scholar
• Menendez R, Perpina M, Torres A. Evaluation of nonresolving and progressive pneumonia. Semin Respir Infect 2003;18:103–11.
   PubMedGoogle Scholar
• Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2000;(2):CD001269.
   Google Scholar
• Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, . Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 2009;361:1260–7.
   PubMed Web of Science ®Google Scholar
• Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994;272:1661–5.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005;366:1165–74.
   PubMed Web of Science ®Google Scholar
• Örtqvist A, Granath F, Askling J, Hedlund J. Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area. Eur Respir J 2007;30:414–22.
   PubMed Web of Science ®Google Scholar
• Govaert TM, Sprenger MJ, Dinant GJ, Aretz K, Masurel N, Knottnerus JA. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine 1994;12:1185–9.
   PubMed Web of Science ®Google Scholar
• Honkanen PO, Keistinen T, Kivela SL. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch Intern Med 1996;156:205–8.
   PubMedGoogle Scholar
• Beyer WE, Palache AM, de Jong JC, Osterhaus AD. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 2002;20:1340–53.
   PubMed Web of Science ®Google Scholar
• Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. Arch Intern Med 1999;159:182–8.
   PubMedGoogle Scholar
• Burls A, Jordan R, Barton P, Olowokure B, Wake B, Albon E, . Vaccinating healthcare workers against influenza to protect the vulnerable—is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine 2006;24:4212–21.
   PubMed Web of Science ®Google Scholar
• Hayward AC, Harling R, Wetten S, Johnson AM, Munro S, Smedley J, . Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 2006;333:1241.
   PubMed Web of Science ®Google Scholar
• Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who work with the elderly. Cochrane Database Syst Rev 2010;(2):CD005187.
   Google Scholar
• Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;(1):CD000422.
   Google Scholar
• Örtqvist A, Hedlund J, Burman L, Elbel E, Hofer M, Leinonen M, . Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group. Lancet 1998;351:399–403.
   PubMed Web of Science ®Google Scholar
• Honkanen PO, Keistinen T, Miettinen L, Herva E, Sankilampi U, Laara E, . Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine 1999; 17:2493–500.
   PubMed Web of Science ®Google Scholar
• Maruyama T, Taguchi O, Niederman MS, Morser J, Kobayashi H, Kobayashi T, . Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ 2010;340:c1004.
   PubMed Web of Science ®Google Scholar
• Christenson B, Hedlund J, Lundbergh P, Ortqvist A. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004;23:363–8.
   PubMed Web of Science ®Google Scholar
• Vila-Corcoles A, Ochoa-Gondar O, Hospital I, Ansa X, Vilanova A, Rodriguez T, . Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clin Infect Dis 2006;43:860–8.
   PubMed Web of Science ®Google Scholar
• Dominguez A, Izquierdo C, Salleras L, Ruiz L, Sousa D, Bayas JM, . Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly. Eur Respir J 2010;36:608–14.
   PubMed Web of Science ®Google Scholar
• Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, . The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453–60.
   PubMed Web of Science ®Google Scholar
• Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993;270:1826–31.
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Boyko EJ, Inui TS, Koepsell TD. Risk factors for acquiring pneumococcal infections. Arch Intern Med 1986;146:2179–85.
   PubMedGoogle Scholar
• de Roux A, Schmole-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, . Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 2008;46:1015–23.
   PubMed Web of Science ®Google Scholar
• Musher DM, Rueda AM, Nahm MH, Graviss EA, Rodriguez-Barradas MC. Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia. J Infect Dis 2008;198:1019–27.
   PubMed Web of Science ®Google Scholar
• Abraham-Van Parijs B. Review of pneumococcal conjugate vaccine in adults: implications on clinical development. Vaccine 2004;22:1362–71.
   PubMed Web of Science ®Google Scholar
• Törling J, Hedlund J, Konradsen HB, Örtqvist Å. Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia. Vaccine 2003;22:96–103.
   PubMed Web of Science ®Google Scholar
• Waites KB, Canupp KC, Chen YY, DeVivo MJ, Nahm MH. Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine. J Spinal Cord Med 2008;31:53–9.
   PubMed Web of Science ®Google Scholar
• Jackson LA, Benson P, Sneller VP, Butler JC, Thompson RS, Chen RT, . Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA 1999;281:243–8.
   PubMed Web of Science ®Google Scholar